(HealthDay)—Adherence to bronchiolitis clinical pathway recommendations is associated with reduced length of stay (LOS) and costs, according to a study published online Feb. 9 in Pediatrics.
(HealthDay) —Emflaza (deflazacort) has been approved by the U.S. Food and Drug Administration to treat Duchenne muscular dystrophy in people five years and older, the agency said Thursday in a news release.
(HealthDay)—For patients with rheumatoid arthritis, etanercept is associated with lower risk for general infections and tuberculosis compared with monoclonal antibody treatment, according to a meta-analysis published online ...
(HealthDay)—For patients with impaired glucose tolerance (IGT), valsartan is associated with reduced incidence of microalbuminuria, according to a study published online Jan. 17 in Diabetes, Obesity and Metabolism.
The use of recreational amphetamine, popularly known as 'speed,' 'ice,' and 'ecstasy,' may hasten the biological ageing of the heart, suggests research, published in the online journal Heart Asia.
A small but clinically important trial of a new ultra-low dose four-in-one pill to treat high blood pressure has produced remarkable results.
Some people in mental health units should be allowed to continue to injure themselves as part of a harm reduction regime, says a researcher with experience of mental health care in the Journal of Medical Ethics.
(HealthDay)—Considerable variation is seen in risk assessment for newborn early onset sepsis (EOS), according to a study published online Feb. 8 in Pediatrics.
(HealthDay)—Renal transplant recipients (RTRs) are often admitted with acute myocardial infarction (AMI), according to a study published in the Feb. 15 issue of The American Journal of Cardiology.
(HealthDay)—Concomitant use of valproic acid (VPA) and meropenem (MEPM) is associated with a decrease in VPA plasma levels, according to a study published online Feb. 1 in the Journal of Clinical Pharmacy and Therapeutics.